Clinical Trial Update: Study of the Oral Treatment MTR-601 in Cervical Dystonia [Phase 2]

View source ↗

Summary

A Phase 2 study of the oral treatment MTR-601 for cervical dystonia has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Dystonia

Drugs mentioned

• MTR-601

Snippet

Sponsor: Motric Bio | Conditions: Cervical Dystonia | Phase 2 | Status: SUSPENDED